Anti ‐viral therapy is associated with improved survival but is underutilised in patients with hepatitis B virus‐related hepatocellular carcinoma: real‐world east and west experience
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 1, Page 44-54, July 2018.
Source: Alimentary Pharmacology and Therapeutics - Category: Drugs & Pharmacology Authors: V. L. Chen
,
M. ‐L. Yeh
,
A. K. Le
,
M. Jun
,
W. K. Saeed
,
J. D. Yang
,
C.‐F. Huang
,
H. Y. Lee
,
P.‐C. Tsai
,
M.‐H. Lee
,
N. Giama
,
N. G. Kim
,
P. P. Nguyen
,
H. Dang
,
H. A. Ali
,
N. Zhang
,
J.‐F. Huang
,
C Source Type: research
More News: Cancer & Oncology | Carcinoma | Drugs & Pharmacology | Hepatitis | Hepatitis B | Hepatocellular Carcinoma | Liver Cancer